Questionnaire sur l'accès aux traitements en EU
- pgarciap
-
Auteur du sujet
- Visiteur
-
il y a 9 ans 3 mois #75
par pgarciap
Questionnaire sur l'accès aux traitements en EU a été créé par pgarciap
Dear Melanoma Patients, Advocates, Carers,
I am a stage IV melanoma patient residing in Belgium. I am the
president and founder of the melanoma independent community advisory
board (M-ICAB). Our purpose is to develop innovative approaches and
solutions for melanoma patients that would not be achievable by single
actors alone, based on a true and meaningful partnership with
researchers/clinicians, the pharmaceutical/diagnostic companies, the EU
and regulatory bodies.
Given the recent approval by FDA and EMA of innovative therapies for
advanced melanoma we are conducting a short survey (6 question maximum 7
minutes) to get a better understanding of the condition of access to
these new treatments across Europe. This information is essential for EU
melanoma patient advocates whom are fighting for their right to a
better quality of life. To facilitate the completion of the survey you
can go to the following link:
www.surveymonkey.com/s/Z7J22F7
Thank you for your participation!
Patricia Garcia-Prieto
President and founder
Melanoma Independent Community Advisory Board
www.m-icab.org/
Volunteer Patient Advocate
European Cancer Patient Coalition
contact: Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.
Member of Advisory Board
Melanoma International Foundation
I am a stage IV melanoma patient residing in Belgium. I am the
president and founder of the melanoma independent community advisory
board (M-ICAB). Our purpose is to develop innovative approaches and
solutions for melanoma patients that would not be achievable by single
actors alone, based on a true and meaningful partnership with
researchers/clinicians, the pharmaceutical/diagnostic companies, the EU
and regulatory bodies.
Given the recent approval by FDA and EMA of innovative therapies for
advanced melanoma we are conducting a short survey (6 question maximum 7
minutes) to get a better understanding of the condition of access to
these new treatments across Europe. This information is essential for EU
melanoma patient advocates whom are fighting for their right to a
better quality of life. To facilitate the completion of the survey you
can go to the following link:
www.surveymonkey.com/s/Z7J22F7
Thank you for your participation!
Patricia Garcia-Prieto
President and founder
Melanoma Independent Community Advisory Board
www.m-icab.org/
Volunteer Patient Advocate
European Cancer Patient Coalition
contact: Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.
Member of Advisory Board
Melanoma International Foundation
Connexion ou Créer un compte pour participer à la conversation.
Temps de génération de la page : 0.168 secondes